Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Clozapine 100mg tablets
0402010C0AAABAB
|
Clozapine | Clozapine | Central Nervous System | 280 |
|
Clozapine 25mg tablets
0402010C0AAAAAA
|
Clozapine | Clozapine | Central Nervous System | 125 |
|
Clozapine 50mg tablets
0402010C0AAACAC
|
Clozapine | Clozapine | Central Nervous System | 82 |
|
Clozapine 200mg tablets
0402010C0AAADAD
|
Clozapine | Clozapine | Central Nervous System | 66 |
|
Denzapine 100mg tablets
0402010C0BCABAB
|
Denzapine | Clozapine | Central Nervous System | 58 |
|
Denzapine 25mg tablets
0402010C0BCAAAA
|
Denzapine | Clozapine | Central Nervous System | 28 |
|
Zaponex 25mg tablets
0402010C0BDAAAA
|
Zaponex | Clozapine | Central Nervous System | 17 |
|
Zaponex 100mg tablets
0402010C0BDABAB
|
Zaponex | Clozapine | Central Nervous System | 16 |
|
Clozaril 100mg tablets
0402010C0BBABAB
|
Clozaril | Clozapine | Central Nervous System | 12 |
|
Clozaril 25mg tablets
0402010C0BBAAAA
|
Clozaril | Clozapine | Central Nervous System | 10 |
|
Clozapine 50mg/ml oral suspension sugar free
0402010C0AAAEAE
|
Clozapine | Clozapine | Central Nervous System | 8 |
|
Zaponex 12.5mg orodispersible tablets
0402010C0BDACAH
|
Zaponex | Clozapine | Central Nervous System | 6 |
|
Zaponex 50mg orodispersible tablets
0402010C0BDAEAJ
|
Zaponex | Clozapine | Central Nervous System | 4 |
|
Denzapine 50mg tablets
0402010C0BCACAC
|
Denzapine | Clozapine | Central Nervous System | 3 |
|
Clozapine 25mg orodispersible tablets sugar free
0402010C0AAAIAI
|
Clozapine | Clozapine | Central Nervous System | 2 |
|
Clozapine 100mg orodispersible tablets sugar free
0402010C0AAAKAK
|
Clozapine | Clozapine | Central Nervous System | 1 |
|
Clozapine 12.5mg orodispersible tablets sugar free
0402010C0AAAHAH
|
Clozapine | Clozapine | Central Nervous System | 1 |
|
Clozapine 100mg/5ml oral liquid
0402010C0AAAFAF
|
Clozapine | Clozapine | Central Nervous System | No data available |
|
Clozapine 200mg orodispersible tablets sugar free
0402010C0AAALAL
|
Clozapine | Clozapine | Central Nervous System | No data available |
|
Clozapine 50mg orodispersible tablets sugar free
0402010C0AAAJAJ
|
Clozapine | Clozapine | Central Nervous System | No data available |
|
Denzapine 200mg tablets
0402010C0BCADAD
|
Denzapine | Clozapine | Central Nervous System | No data available |
|
Denzapine 50mg/ml oral suspension
0402010C0BCAEAE
|
Denzapine | Clozapine | Central Nervous System | No data available |
|
Zaponex 100mg orodispersible tablets
0402010C0BDAFAK
|
Zaponex | Clozapine | Central Nervous System | No data available |
|
Zaponex 200mg orodispersible tablets
0402010C0BDAGAL
|
Zaponex | Clozapine | Central Nervous System | No data available |
|
Zaponex 25mg orodispersible tablets
0402010C0BDADAI
|
Zaponex | Clozapine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.